FDA NDC Directory · JSON-LD · Markdown

Baxdela

NDC 70842-101 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namedelafloxacin meglumine
Labeler / ManufacturerMelinta Therapeutics, LLC
Marketing categoryNew Drug Application (innovator) · App NDA208610
Dosage form / routeTABLET · ORAL
Active ingredientsDELAFLOXACIN MEGLUMINE (450 mg/1)
Marketing started20170619
Package count3

External sources

Source: openFDA. Public-domain (CC0).